Skip to content

Comparing different concentrations of oxytocin to augment slow labour in obese mothers

High vs. standard concentration oxytocin solution for labour augmentation in obese multiparas: a double blind randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11484372
Enrollment
126
Registered
2025-04-09
Start date
2025-04-15
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labour dystocia (abnormal labour progress) Pregnancy and Childbirth

Interventions

A randomisation sequence is generated using an online randomiser in blocks of 4 or 8 (1-to-1 ratio) by an investigator not involved in study recruitment. Participants will be randomised by the opening

Sponsors

University Malaya Medical Centre
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. BMI =27.5 kg/m2 (Asian definition of obesity) 2. Spontaneous labour (contraction >2:10 minutes and cervical dilatation =3cm) 3. Inadequate progress as clinically determined 4. Multiparous (at least one prior vaginal delivery) 5. Term =37 weeks gestation 6. Age 18-45 years old 7. Membranes ruptured (including prelabour rupture of membranes) 8. Singleton pregnancy 9. Cephalic presentation 10. Reassuring fetal heart rate tracing at initiation of oxytocin infusion

Exclusion criteria

Exclusion criteria: 1. Induced labour (prior Foley, prostaglandin or oxytocin) 2. Previous uterine scar (caesarean/myomectomy/perforation) 3. Known major fetal anomaly 4. Fetal weight clinically estimated to be =2 kg & =4 kg and subsequently confirmed by ultrasound 5. Grand multiparous (parity =5)

Design outcomes

Primary

MeasureTime frame
Start of oxytocin infusion to birth interval measured using data collected from the patient's electronic medical record at one timepoint

Secondary

MeasureTime frame
The secondary outcome measures were assessed from data collected from the electronic medical record at one timepoint, unless stated: 1. Maximum oxytocin infusion rate used 2. Duration of oxytocin infusion 3. Total volume infused 4. Cardiotocographic abnormality (through first stage of labour)-assessed by a blinded assessor 4.1. Tachysystole (contractions =6 in 10 minutes) 4.2. Hypertonus (sustained contraction =2 minutes) 4.3. Hyperstimulation syndrome (tachysystole and/or hypertonus with concurrent fetal deceleration [defined as a decrease in fetal heart rate of =15 bpm from baseline for =15 seconds]) 5. Number of doses of tocolytic given, if any 6. Mode of delivery 6.1. Spontaneous vaginal 6.2. Vacuum 6.3. Forceps 6.4. Caesarean section 7. Indication for caesarean section 8. Indication for instrumental vaginal delivery 9. Maternal satisfaction with the birth process measured using an 11-point 0-10 NRS – numerical rating scale, after delivery (higher score, greater satisfaction) 10. Blood loss during delivery 11. Third- or fourth-degree tear 12. Maternal infection 13. Intrapartum therapeutic antibiotics (excluding prophylactic antibiotics) 14. Epidural in labour 15. Length of hospital stay 16. ICU admission 17. Cardiorespiratory arrest 18. Needing a hysterectomy 19. Neonatal outcomes 19.1. Apgar score at 1 and 5 minutes 19.2. NICU admission 19.3. Cord pH 19.4. Neonatal sepsis 19.5. Birth weight 19.6. Birth trauma 19.7. Hypoxic ischaemic encephalopathy/need for therapeutic hypothermia Major harm 20. Neonatal hypoxic ischaemic-encephalopathy requiring cooling therapy due to uterine hyperstimulation syndrome 21. Maternal convulsions due to water intoxication

Countries

Malaysia

Contacts

Public ContactMuhammad Ariff;Tan Saari;Peng Chiong

;

ariffsaari2@gmail.com;tanpengchiong@yahoo.com+60 0133409148;+60 0123052970

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026